← Leaderboard
AMGN
Ticker
AMGN
Amgen Inc.
Healthcare
Congressional Trades
75
by 19 members
Ticker Intelligence Brief
Who in Congress traded AMGN, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Latest receipt
David Taylor
BUY · 2026-06-05
Largest range
$50K – $100K
C. Franklin
Slowest filing
330d
C. Franklin
Best vs SPY
19.8%
Lisa McClain
Buys
36
48%
Sells
35
47%
Total Volume
$1.3M
midpoint
Unique Traders
19
members
Party Breakdown
Democrats27 · 36%
Republicans48 · 64%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthALIGNEDBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
—
Oct '22
1▲
1▲
Dec '22
—
—
Jun '23
0▲1▼
—
Jan '24
0▲1▼
0▲1▼
May '24
—
1▲
Jul '24
—
0▲1▼
Aug '24⚡
3▲
1▲2▼
Sep '24
—
2▲
Oct '24
1▲
1▲1▼
Nov '24
0▲1▼
—
Dec '24
2▲
1▲2▼
Jan '25
—
—
Feb '25
2▲2▼
2▲
Apr '25⚡
2▲3▼
—
May '25
0▲3▼
—
Jun '25
5▲
0▲3▼
Sep '25
0▲2▼
—
Dec '25
0▲2▼
0▲1▼
Jan '26
2▲2▼
1▲
Feb '26⚡
0▲2▼
0▲1▼
Mar '26⚡
2▲
0▲1▼
Apr '26
0▲2▼
2▲1▼
May '26
—
—
Jun '26
2▲
Democrats12▲14▼Neutral
vs
Republicans22▲21▼Neutral
Net buyingNet selling⚡ Party split
💼 Lobbying Filings
all →- 2026-06-12$5KAMGEN INC.Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests
- 2026-06-12$0AMGEN INC.Educating members on issues affecting Amgen and patients
- 2026-06-02$0AMGEN INC.Issues related to the implementation of the Medicare Drug Negotiations and the calculation of the Medicaid Rebate and Best Price. issues relating to MFN pricing and other price controls in drugs.
- 2026-06-01$0AMGEN INC.Issues related to drug pricing and reimbursement for prescription drugs.
- 2026-04-22$10KAMGEN INC.Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests
- 2026-04-20$2.6MAMGEN INCIssues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Ac
- 2026-04-20$80KAMGEN INC.Medicare/Medicaid payment reform. Implementation of Inflation Reduction Act of 2022. Prescription Drug Pricing Policy. Supply Chain Issues. Prescription drug pricing policy.
- 2026-04-20$60KAMGEN INC.Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 Issues related to visas
- 2026-04-20$60KAMGEN INC.General education about federal policies impacting pharmaceutical development, approval, and patient access. 340B, Policies impacting public health preparedness and prevention. Policies impacting Cardiovascular and bone health. Pharmacy benefit manager reform proposals. FDA reform, prescription drug reimportation and new proposals. Medicare Part D and Medicare Part B drug reimbursement, policies around MFN drug pricing, Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act" implementation, coverage and access for biosimilars. Tax issues related to the pharmaceutical industry. Implementation of PL 119-21. Policies impacting disease prevention. Issues related to antitrust legislation. Issues related to patent protections.
- 2026-04-20$60KAMGEN INCIRA, drug pricing in federal programs, biosimilars, orphan drugs, prescription drug access & reimbursement, FDA issues, transparency Medicare coverage and reimbursement issues, Medicare Part B reimbursement, transparency, prescription drug pricing and access, drug pricing in federal programs federal budget issues
Congressional Momentum
buy vs. sell pressureDISTRIBUTINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
▲100
3 buys3 total0 sells
$49K buys · $0 sells
Last 90 Days
▼33
4 buys9 total5 sells
$81K buys · $163K sells
All-Time
–46
36 buys75 total39 sells
$576K buys · $680K sells
Cumulative Net Position (buy vol − sell vol)
-$104K
2018-1275 trades plotted2026-06
Best Timers
avg excess return vs SPY · AMGN trades only15 members w/ alpha dataExcess return = stock price change minus SPY change over the same holding window.Congress avg: -4.8%· 33% of traders beat SPY on this name
Top Alpha Generators
D:3R:7House:9Senate:1
underperformed SPY|beat SPY
Worst Timers
bottom 5 by avg excess return
underperformed SPY|beat SPY
Worst single trade: Ro Khanna (-29.9%)Best single trade: Lisa McClain (+19.8%)
Timing Fingerprint
filing delay vs. excess return over SPY · 49 tradesCongress avg -6.8% vs SPYEach dot = one disclosed trade. X-axis = days between trade and STOCK Act filing.Y-axis = return above (or below) SPY over the subsequent holding window. Upper-right = late filers who beat the market.
31% of trades beat SPYavg excess -6.8%avg delay 49d25 buys24 sellsBuySellOther· dot size ∝ trade size
Congress Swarm Events
synchronized trading — 3+ members within 21 daysSUSPICIOUSA swarm event occurs when 3 or more members disclose trades in AMGN within a rolling 21-day window. Tight windows with high directional consensus score highest on the suspicion meter.
🔴 #1MIXED5 members · 8d span
54
Window
2025-04-08 → 2025-04-16
▲ 4 buys▼ 3 sells$154K vol
Consensus
57%
RRobert Bresnahan2025-04-08
DRo Khanna2025-04-09
RJefferson Shreve2025-04-112×
RTommy Tuberville2025-04-152×
DJared Moskowitz2025-04-16
🟠 #2MIXED3 members · 21d span
36
Window
2024-11-15 → 2024-12-06
▲ 2 buys▼ 2 sells$57K vol
Consensus
50%
DRo Khanna2024-11-15
RJulia Letlow2024-11-19
RVirginia Foxx2024-12-062×
2 swarm events detectedmax members in single event: 5highest suspicion score: 5421-day rolling window · top 6 by score
Trade Activity Timeline
Congressional buys & sells by month · last 24 months w/ activity
22/10
22/12
23/06
24/01
24/05
24/07
24/08
24/09
24/10
24/11
24/12
25/01
25/02
25/04
25/05
25/06
25/09
25/12
26/01
26/02
26/03
26/04
26/05
26/06
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade13 buyers ·14 sellers
BuySellOtherDot size ∝ trade size · top 15 most-active traders shown
4 less-active traders not shown.
Seasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Net buyingNet sellingNo trades · number = trade count
Peak buy month: Jun · Peak sell month: Sep
Congressional Conviction Timeline
net positioning · alpha track recordMIXED36 buys39 sellscumulative α -240.8%30mo tracked
Monthly Net Flow (Buys − Sells)
Cumulative Excess Return on Congressional Buys vs SPY
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2026-06-05 | RDavid Taylor | BUY | $1K – $15K | 10d | receipt → |
| 2026-06-05 | RDavid Taylor | BUY | $1K – $15K | 7d | receipt → |
| 2026-05-27 | DRo Khanna | BUY | $15K – $50K | 13d | receipt → |
| 2026-05-15 | DRo Khanna | SELL | $15K – $50K | 25d | receipt → |
| 2026-05-01 | DRo Khanna | BUY | $15K – $50K | 39d | receipt → |
| 2026-04-17 | RMaria Salazar | SELL | $15K – $50K | 24d | receipt → |
| 2026-04-24 | DRo Khanna | SELL | $15K – $50K | 17d | receipt → |
| 2026-04-17 | RMaria Salazar | SELL | $15K – $50K | 21d | receipt → |
| 2026-03-24 | RMaria Salazar | BUY | $15K – $50K | 29d | receipt → |
| 2026-03-24 | RMaria Salazar | BUY | $15K – $50K | 28d | receipt → |
| 2026-03-30 | DRo Khanna | SELL | $15K – $50K | 8d | receipt → |
| 2026-02-26 | RDavid Taylor | SELL | $1K – $15K | 11d | receipt → |
| 2026-02-24 | DRo Khanna | BUY | $15K – $50K | 13d | receipt → |
| 2026-02-26 | RDavid Taylor | SELL | $1K – $15K | 8d | receipt → |
| 2026-01-23 | DRo Khanna | SELL | $15K – $50K | 14d | receipt → |
| 2026-01-29 | RDavid Taylor | SELL | $1K – $15K | 5d | receipt → |
| 2026-01-16 | RDavid Taylor | BUY | $1K – $15K | 18d | receipt → |
| 2026-01-29 | RDavid Taylor | SELL | $1K – $15K | 4d | receipt → |
| 2026-01-16 | RDavid Taylor | BUY | $1K – $15K | 17d | receipt → |
| 2024-11-19 | RJulia Letlow | SELL | $1K – $15K | 420d | receipt → |
| 2024-10-23 | RJulia Letlow | BUY | $1K – $15K | 447d | receipt → |
| 2025-12-03 | RDavid Taylor | SELL | $1K – $15K | 5d | receipt → |
| 2025-12-03 | RDavid Taylor | SELL | $1K – $15K | 2d | receipt → |
| 2025-09-25 | RLisa McClain | SELL | $1K – $15K | 28d | receipt → |
| 2025-09-25 | RLisa McClain | SELL | $1K – $15K | 27d | receipt → |
| 2025-09-04 | DSheldon Whitehouse | SELL | $1K – $15K | 29d | receipt → |
| 2025-09-29 | DRo Khanna | SELL | $1K – $15K | 4d | receipt → |
| 2025-09-04 | DSheldon Whitehouse | SELL | $1K – $15K | 29d | receipt → |
| 2025-02-11 | RDaniel Meuser | SELL | $1K – $15K | 190d | receipt → |
| 2025-06-24 | RLisa McClain | BUY | $1K – $15K | 51d | receipt → |
| 2025-06-24 | RLisa McClain | BUY | $1K – $15K | 50d | receipt → |
| 2025-06-06 | RCliff Bentz | BUY | $1K – $15K | 34d | receipt → |
| 2025-06-06 | RCliff Bentz | BUY | $1K – $15K | 33d | receipt → |
| 2024-08-07 | RC. Franklin | BUY | $1K – $15K | 330d | receipt → |
| 2025-06-06 | RCliff Bentz | BUY | $1K – $15K | 25d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 42d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 41d | receipt → |
| 2025-04-15 | RTommy Tuberville | SELL | $15K – $50K | 31d | receipt → |
| 2025-04-15 | RTommy Tuberville | SELL | $15K – $50K | 30d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 3d | receipt → |
| 2025-04-09 | DRo Khanna | BUY | $1K – $15K | 33d | receipt → |
| 2025-04-16 | DJared Moskowitz | BUY | $1K – $15K | 23d | receipt → |
| 2025-04-11 | RJefferson Shreve | BUY | $15K – $50K | 27d | receipt → |
| 2025-04-08 | RRobert Bresnahan | SELL | $1K – $15K | 30d | receipt → |
| 2025-04-11 | RJefferson Shreve | BUY | $15K – $50K | 14d | receipt → |
| 2025-02-24 | RJefferson Shreve | BUY | $15K – $50K | 13d | receipt → |
| 2025-02-24 | RJefferson Shreve | BUY | $15K – $50K | 5d | receipt → |
| 2025-01-06 | DEmily Randall | SELL | $1K – $15K | 36d | receipt → |
| 2025-02-11 | RDaniel Meuser | SELL | $1K – $15K | 0d | receipt → |
| 2025-01-06 | DEmily Randall | SELL | $1K – $15K | 35d | receipt → |
| 2025-01-22 | DRo Khanna | BUY | $1K – $15K | 15d | receipt → |
| 2024-12-06 | RVirginia Foxx | BUY | $1K – $15K | 31d | receipt → |
| 2024-12-06 | RVirginia Foxx | BUY | $1K – $15K | 31d | receipt → |
| 2024-11-15 | DRo Khanna | SELL | $15K – $50K | 20d | receipt → |
| 2024-11-12 | DRo Khanna | BUY | $1K – $15K | 23d | receipt → |
| 2024-10-14 | DRo Khanna | BUY | $1K – $15K | 25d | receipt → |
| 2024-10-11 | DRo Khanna | BUY | $1K – $15K | 28d | receipt → |
| 2024-09-17 | DSheldon Whitehouse | PARTIAL_SELL | $1K – $15K | 24d | receipt → |
| 2024-09-17 | DSheldon Whitehouse | PARTIAL_SELL | $1K – $15K | 23d | receipt → |
| 2024-09-09 | DRo Khanna | BUY | $1K – $15K | 25d | receipt → |
| 2024-08-02 | DRo Khanna | SELL | $15K – $50K | 35d | receipt → |
| 2024-08-07 | RC. Franklin | BUY | $50K – $100K | 13d | receipt → |
| 2024-08-02 | RC. Franklin | BUY | $1K – $15K | 18d | receipt → |
| 2024-07-02 | DRo Khanna | BUY | $1K – $15K | 36d | receipt → |
| 2024-05-29 | DRo Khanna | SELL | $15K – $50K | 7d | receipt → |
| 2024-01-19 | RTommy Tuberville | SELL | $15K – $50K | 27d | receipt → |
| 2020-11-05 | RBill Cassidy | SELL | $1K – $15K | 1104d | receipt → |
| 2023-06-12 | RShelley Capito | SELL | $1K – $15K | 77d | receipt → |
| 2022-10-06 | RTommy Tuberville | BUY | $1K – $15K | 326d | receipt → |
| 2022-01-12 | RTommy Tuberville | BUY | $1K – $15K | 593d | receipt → |
| 2021-12-15 | RShelley Capito | BUY | $1K – $15K | 621d | receipt → |
| 2020-03-09 | RBill Cassidy | PARTIAL_SELL | $1K – $15K | 1267d | receipt → |
| 2019-02-04 | DJohn Reed | SELL | $1K – $15K | 1666d | receipt → |
| 2018-12-07 | RBill Cassidy | PARTIAL_SELL | $1K – $15K | 1725d | receipt → |
| 2022-12-09 | DJosh Gottheimer | BUY | $1K – $15K | 26d | receipt → |